Cargando…
Ventana immunohistochemistry assay for anaplastic lymphoma kinase gene rearrangement detection in patients with non‐small cell lung cancer: A meta‐analysis
BACKGROUND: The aim of this study was to evaluate the diagnostic value of Ventana immunohistochemistry (IHC) assay for anaplastic lymphoma kinase (ALK) gene rearrangement screening in patients with non‐small cell lung cancer (NSCLC). METHODS: Open published studies that reported the diagnostic perfo...
Autores principales: | Zhiwei, Wang, Yuan, Jiang, Yihui, Yao, Xin, Hou, Jingtao, Chen, Lei, Shi, Yongjian, Duan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582490/ https://www.ncbi.nlm.nih.gov/pubmed/28742247 http://dx.doi.org/10.1111/1759-7714.12468 |
Ejemplares similares
-
Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening
por: Lee, Jeeyun, et al.
Publicado: (2015) -
Evaluation of immunohistochemistry using two different antibodies and procedures for primary lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangement
por: AKIBA, JUN, et al.
Publicado: (2014) -
Discordance between Fluorescence In Situ Hybridization and Immunohistochemistry Analysis of Anaplastic Lymphoma Kinase Rearrangement in Indian Patients with Non-Small Cell Lung Cancer
por: Kumar, Manish, et al.
Publicado: (2020) -
Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma
por: Subbiah, V., et al.
Publicado: (2021) -
Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer
por: Kauffmann-Guerrero, Diego, et al.
Publicado: (2020)